For all the innovation, engineering, and miniaturization that has helped to refine surgical and transcatheter aortic valve replacement over the last few decades, they still fall short of ideal. That ...
For the rising number of patients needing aortic reintervention, transcatheter aortic valve replacement (TAVR) explantation carried the highest mortality risk, two registry analyses affirmed. In ...
TCT 898: Successful Closure of Transcatheter Aortic Valve Replacement-Induced Gerbode Defect With Valve-in-Valve Technique: A Case Report Receive the the latest news, research, and presentations from ...
Please provide your email address to receive an email when new articles are posted on . NEW ORLEANS — Transcatheter aortic valve replacement in failing transcatheter valves may not be feasible in ...
FDA approved the Sapien 3 transcatheter aortic valve replacement (TAVR) platform for treatment of severe aortic stenosis early in the disease process while patients still had no symptoms or other ...
SAN FRANCISCO — Among patients with symptomatic, severe native aortic regurgitation at high surgical risk, the JenaValve Trilogy transcatheter heart valve system (JenaValve Technology) met its primary ...
Six months after aortic valve replacement, many people can return to typical activities like exercising, socializing, and working. However, the recovery timeline can vary from person to person. One of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results